Podcast Medicom Medical Publishers

ASCO20 Virtual Science Meeting - Highlights

June 03, 2020
Podcast Medicom Medical Publishers
ASCO20 Virtual Science Meeting - Highlights
Show Notes Chapter Markers

Summary of 6 articles presented at the ASCO20 Virtual Meeting:

  1. CASPIAN - ES-SCLC: tremelimumab + durvalumab + chemotherapy misses endpoint
  2. E2108 - Advanced breast cancer: locoregional therapy does not improve OS
  3. EORTC 1325/KEYNOTE-054 - Adjuvant pembrolizumab: durable RFS for Stage III melanoma
  4. JAVELIN Bladder 100 - Urothelial cancer: avelumab works as maintenance therapy
  5. KEYNOTE-177 - Pembrolizumab as first-line in MSI-H mCRC
  6. ADAURA - Adjuvant osimertinib in NSCLC: practice changing ADAURA trial
CASPIAN - ES-SCLC: tremelimumab + durvalumab + chemotherapy misses endpoint
E2108 - Advanced breast cancer: locoregional therapy does not improve OS
EORTC 1325/KEYNOTE-054 - Adjuvant pembrolizumab: durable RFS for Stage III melanoma
JAVELIN Bladder 100 - Urothelial cancer: avelumab works as maintenance therapy
KEYNOTE-177 - Pembrolizumab as first-line in MSI-H mCRC
ADAURA - Adjuvant osimertinib in NSCLC: practice changing ADAURA trial